当前位置:首页 - 行情中心 - 新天药业(002873) - 财务分析 - 现金流量表

新天药业

(002873)

  

流通市值:29.17亿  总市值:29.83亿
流通股本:2.39亿   总股本:2.44亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金412,246,948.31196,272,034.32835,540,586.47615,444,345.49
  收到其他与经营活动有关的现金7,056,310.393,068,574.7419,626,21915,078,978.98
  经营活动现金流入小计419,303,258.7199,340,609.06855,166,805.47630,523,324.47
  购买商品、接受劳务支付的现金56,511,146.1927,942,700.9117,686,758.8694,038,408.3
  支付给职工以及为职工支付的现金153,551,106.7382,463,582.3344,678,351.36252,484,372.61
  支付的各项税费41,358,453.7917,739,875.2279,863,239.4854,647,547.35
  支付其他与经营活动有关的现金100,695,451.8555,208,314.83224,808,241.44174,654,760.41
  经营活动现金流出小计352,116,158.56183,354,473.25767,036,591.14575,825,088.67
  经营活动产生的现金流量净额67,187,100.1415,986,135.8188,130,214.3354,698,235.8
二、投资活动产生的现金流量:
  收回投资收到的现金15,000,000-963.69-
  取得投资收益收到的现金7,132.6---
  处置固定资产、无形资产和其他长期资产收回的现金净额1,880,000-15,080,0005,080,000
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计16,887,132.6-15,080,963.695,080,000
  购建固定资产、无形资产和其他长期资产支付的现金20,577,344.4811,454,754.561,453,256.6149,997,770.24
  投资支付的现金15,000,000---
  投资活动现金流出小计35,577,344.4811,454,754.561,453,256.6149,997,770.24
  投资活动产生的现金流量净额-18,690,211.88-11,454,754.5-46,372,292.92-44,917,770.24
三、筹资活动产生的现金流量:
  取得借款收到的现金287,000,000182,000,000680,000,000509,000,000
  筹资活动现金流入小计287,000,000182,000,000680,000,000509,000,000
  偿还债务支付的现金324,700,000190,100,000577,290,300364,000,000
  分配股利、利润或偿付利息支付的现金32,126,880.3313,622,640.6435,060,370.1829,858,006.69
  支付其他与筹资活动有关的现金2,366,869.461,215,146.72129,479,757.56126,443,138.36
  筹资活动现金流出小计359,193,749.79204,937,787.36741,830,427.74520,301,145.05
  筹资活动产生的现金流量净额-72,193,749.79-22,937,787.36-61,830,427.74-11,301,145.05
五、现金及现金等价物净增加额-23,696,861.53-18,406,406.05-20,072,506.33-1,520,679.49
  加:期初现金及现金等价物余额118,164,427.88118,164,427.88138,236,934.21138,236,934.21
  期末现金及现金等价物余额94,467,566.3599,758,021.83118,164,427.88136,716,254.72
补充资料:
  净利润5,766,078.35-52,322,877.14-
  资产减值准备794,961.84-4,567,339.52-
  固定资产和投资性房地产折旧14,095,003.36-27,667,894.47-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,095,003.36-27,667,894.47-
  无形资产摊销3,102,512.18-4,620,991.77-
  长期待摊费用摊销3,232,654.83-1,613,341.91-
  处置固定资产、无形资产和其他长期资产的损失845,407.25--18,900,390.64-
  固定资产报废损失102,309.47-568,011.3-
  公允价值变动损失22,823.1--24,344.64-
  财务费用8,963,130.17-21,505,187.56-
  投资损失-6,728.87---
  递延所得税-281,608.67-1,325,822.89-
  其中:递延所得税资产减少-233,256.98-264,671.35-
    递延所得税负债增加-48,351.69-1,061,151.54-
  存货的减少-1,582,545.69-35,800,825.98-
  经营性应收项目的减少34,851,725.22--38,027,571.31-
  经营性应付项目的增加-5,245,334.82--9,996,221.52-
  不涉及现金收支的投资和筹资活动金额其他项目--3,807,226.68-
  现金的期末余额94,467,566.35-118,164,427.88-
  减:现金的期初余额118,164,427.88-138,236,934.21-
  现金及现金等价物的净增加额-23,696,861.53--20,072,506.33-
公告日期2025-07-312025-04-252025-04-252024-10-28
审计意见(境内)标准无保留意见
TOP↑